Literature DB >> 28962888

Nonsyndromic Peripheral Pulmonary Artery Stenosis Is Associated With Homozygosity of RNF213 p.Arg4810Lys Regardless of Co-occurrence of Moyamoya Disease.

Sung-A Chang1, Ju Sun Song2, Taek Kyu Park1, Jeong Hoon Yang1, Woo Chan Kwon1, So Ree Kim1, Sung Mok Kim3, Jihoon Cha3, Shin Yi Jang1, Young Seok Cho4, Tae Jung Kim3, Oh Young Bang5, Jin Young Song6, Chang-Seok Ki2, Duk-Kyung Kim7.   

Abstract

BACKGROUND: Peripheral pulmonary arterial stenosis (PPAS) in childhood is frequently associated with other syndromes; however, PPAS in adolescents and adults is rare and its etiology is not well understood. We report the clinical characteristics of adult-onset nonsyndromic PPAS associated with the p.Arg4810Lys variant of the RNF213 gene.
METHODS: We recently encountered an index case of severe pulmonary hypertension with multiple PPAS and intra- and extracranial arteriopathy. Because of a family history of Moyamoya disease (MMD), genetic analysis was performed, and revealed that this patient was homozygous for RNF213 p.Arg4810Lys. We searched for PPAS by reviewing the pulmonary hypertension registry and the MMD registry, and found four more cases of PPAS. Clinical features of the five patients and their families were analyzed.
RESULTS: Mean age at diagnosis of pulmonary hypertension was 26 years, and the male to female ratio was 4:1. Genetic analysis of four patients revealed that all these patients were homozygous for the RNF213 p.Arg4810Lys variant. Pulmonary angiograms showed a string of beads pattern and/or diffuse stenosis of peripheral pulmonary arteries. Notably, three patients had MMD, whereas two patients did not. The three MMD patients had multiple stenoses of extracranial arteries other than the pulmonary artery.
CONCLUSIONS: PPAS in segmental or subsegmental arteries in adulthood with multiple extracranial vasculopathies was found to be associated with homozygosity for RNF213 p.Arg4810Lys. RNF213 variant-associated vasculopathy should be categorized as a discrete disease entity of adulthood-onset PPAS regardless of the presence of MMD.
Copyright © 2017 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Moyamoya disease; homozygote; peripheral pulmonary arterial stenosis; pulmonary hypertension

Mesh:

Substances:

Year:  2017        PMID: 28962888     DOI: 10.1016/j.chest.2017.09.023

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  15 in total

1.  Cardiac manifestations in a western moyamoya disease population: a single-center descriptive study and review.

Authors:  Anthony S Larson; Luis Savastano; James Klaas; Giuseppe Lanzino
Journal:  Neurosurg Rev       Date:  2020-06-07       Impact factor: 3.042

2.  Genome-Wide Association Study of Intracranial Artery Stenosis Followed by Phenome-Wide Association Study.

Authors:  Shogo Dofuku; Kyuto Sonehara; Satoru Miyawaki; Saori Sakaue; Hideaki Imai; Masahiro Shimizu; Hiroki Hongo; Yuki Shinya; Kenta Ohara; Yu Teranishi; Atsushi Okano; Hideaki Ono; Hirofumi Nakatomi; Akira Teraoka; Kenichi Yamamoto; Yuichi Maeda; Takuro Nii; Toshihiro Kishikawa; Ken Suzuki; Jun Hirata; Meiko Takahashi; Koichi Matsuda; Atsushi Kumanogoh; Fumihiko Matsuda; Yukinori Okada; Nobuhito Saito
Journal:  Transl Stroke Res       Date:  2022-06-14       Impact factor: 6.829

3.  RNF213 p.Arg4810Lys Heterozygosity in Moyamoya Disease Indicates Early Onset and Bilateral Cerebrovascular Events.

Authors:  Daiichiro Ishigami; Satoru Miyawaki; Hideaki Imai; Masahiro Shimizu; Hiroki Hongo; Shogo Dofuku; Kenta Ohara; Yu Teranishi; Daisuke Shimada; Satoshi Koizumi; Hideaki Ono; Yudai Hirano; Masafumi Segawa; Hirofumi Nakatomi; Nobuhito Saito
Journal:  Transl Stroke Res       Date:  2021-10-30       Impact factor: 6.829

4.  Pulmonary arterial hypertension in the modern era: The intersection of genotype and phenotype.

Authors:  Nicole F Ruopp; Bradley A Maron
Journal:  J Heart Lung Transplant       Date:  2019-11-09       Impact factor: 10.247

5.  High prevalence of deleterious mutations in concomitant nonsyndromic cleft and outflow tract heart defects.

Authors:  Naikhoba C O Munabi; Shady Mikhail; Omar Toubat; Michelle Webb; Allyn Auslander; Pedro A Sanchez-Lara; Zarko Manojlovic; Ryan J Schmidt; David Craig; William P Magee; Subramanyan Ram Kumar
Journal:  Am J Med Genet A       Date:  2022-04-06       Impact factor: 2.578

6.  Rare variants in RNF213, a susceptibility gene for moyamoya disease, are found in patients with pulmonary hypertension and aggravate hypoxia-induced pulmonary hypertension in mice.

Authors:  Hatasu Kobayashi; Risako Kabata; Hideyuki Kinoshita; Takaaki Morimoto; Koh Ono; Midori Takeda; Jungmi Choi; Hiroko Okuda; Wanyang Liu; Kouji H Harada; Takeshi Kimura; Shohab Youssefian; Akio Koizumi
Journal:  Pulm Circ       Date:  2018-05-02       Impact factor: 3.017

7.  ST-Elevation Myocardial Infarction (STEMI) in a Patient with Moyamoya Disease.

Authors:  James Livesay; Jeffrey Johnson
Journal:  Case Rep Cardiol       Date:  2019-02-04

8.  Ring Finger Protein 213 Variant and Plaque Characteristics, Vascular Remodeling, and Hemodynamics in Patients With Intracranial Atherosclerotic Stroke: A High-Resolution Magnetic Resonance Imaging and Hemodynamic Study.

Authors:  Eun-Hyeok Choi; Hanul Lee; Jong-Won Chung; Woo-Keun Seo; Gyeong-Moon Kim; Chang-Seok Ki; Yoon-Chul Kim; Oh Young Bang
Journal:  J Am Heart Assoc       Date:  2019-10-08       Impact factor: 5.501

9.  A histopathological report of a 16-year-old male with peripheral pulmonary artery stenosis and Moyamoya disease with a homozygous RNF213 mutation.

Authors:  Kei Takahashi; Junichi Nakamura; Shinya Sakiyama; Toshitaka Nakaya; Takahiro Sato; Taku Watanabe; Hiroshi Ohira; Keishi Makita; Utano Tomaru; Akihiro Ishizu; Ichizo Tsujino
Journal:  Respir Med Case Rep       Date:  2019-12-14

Review 10.  Moyamoya Disease and Spectrums of RNF213 Vasculopathy.

Authors:  Oh Young Bang; Jong-Won Chung; Dong Hee Kim; Hong-Hee Won; Je Young Yeon; Chang-Seok Ki; Hyung Jin Shin; Jong-Soo Kim; Seung Chyul Hong; Duk-Kyung Kim; Akio Koizumi
Journal:  Transl Stroke Res       Date:  2019-10-24       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.